 Martin Boublik
Concepts (304)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Football | 8 | 2022 | 85 | 2.470 |
Why?
| | Tendon Injuries | 5 | 2018 | 68 | 1.330 |
Why?
| | Ribosomes | 30 | 1994 | 186 | 1.200 |
Why?
| | Soccer | 1 | 2022 | 42 | 0.760 |
Why?
| | Return to Sport | 1 | 2022 | 97 | 0.740 |
Why?
| | Escherichia coli | 33 | 1994 | 815 | 0.630 |
Why?
| | Pectoralis Muscles | 1 | 2018 | 18 | 0.600 |
Why?
| | RNA, Ribosomal | 15 | 1994 | 168 | 0.570 |
Why?
| | Ribosomal Proteins | 17 | 1994 | 93 | 0.560 |
Why?
| | Knee Injuries | 4 | 2011 | 99 | 0.480 |
Why?
| | Athletic Injuries | 4 | 2022 | 529 | 0.460 |
Why?
| | Brain Concussion | 1 | 2022 | 574 | 0.460 |
Why?
| | Patellar Ligament | 2 | 2011 | 27 | 0.380 |
Why?
| | Anterior Cruciate Ligament Injuries | 3 | 2011 | 159 | 0.380 |
Why?
| | Bone-Patellar Tendon-Bone Grafting | 1 | 2010 | 11 | 0.350 |
Why?
| | Arthritis, Infectious | 1 | 2010 | 69 | 0.320 |
Why?
| | Groin | 1 | 2009 | 9 | 0.310 |
Why?
| | Orthopedic Procedures | 1 | 2011 | 216 | 0.300 |
Why?
| | Microscopy, Electron | 26 | 1993 | 443 | 0.250 |
Why?
| | RNA, Ribosomal, 16S | 4 | 1991 | 549 | 0.210 |
Why?
| | Nucleic Acid Conformation | 17 | 1994 | 728 | 0.210 |
Why?
| | Postoperative Complications | 2 | 2010 | 2654 | 0.170 |
Why?
| | Anterior Cruciate Ligament | 2 | 2011 | 81 | 0.170 |
Why?
| | RNA, Transfer | 6 | 1991 | 138 | 0.160 |
Why?
| | Athletes | 1 | 2022 | 423 | 0.150 |
Why?
| | Recovery of Function | 2 | 2013 | 653 | 0.140 |
Why?
| | Circular Dichroism | 17 | 1990 | 149 | 0.130 |
Why?
| | Microscopy, Electron, Scanning | 7 | 1994 | 201 | 0.130 |
Why?
| | Artemia | 4 | 1992 | 8 | 0.130 |
Why?
| | RNA, Transfer, Amino Acyl | 3 | 1993 | 9 | 0.130 |
Why?
| | Rupture | 2 | 2013 | 92 | 0.110 |
Why?
| | Thigh | 2 | 2013 | 48 | 0.110 |
Why?
| | Macromolecular Substances | 8 | 1993 | 229 | 0.110 |
Why?
| | Treatment Outcome | 5 | 2013 | 10811 | 0.110 |
Why?
| | Return to Work | 1 | 2013 | 21 | 0.100 |
Why?
| | Peptide Elongation Factor Tu | 1 | 1993 | 5 | 0.100 |
Why?
| | Transplantation, Autologous | 2 | 2011 | 238 | 0.100 |
Why?
| | Molecular Weight | 5 | 1993 | 335 | 0.100 |
Why?
| | Shoulder Injuries | 1 | 1993 | 58 | 0.100 |
Why?
| | Microscopy, Electron, Scanning Transmission | 1 | 1992 | 4 | 0.100 |
Why?
| | Transplantation, Homologous | 2 | 2011 | 416 | 0.100 |
Why?
| | Knee Prosthesis | 1 | 1993 | 27 | 0.100 |
Why?
| | Arthritis, Juvenile | 1 | 1993 | 56 | 0.100 |
Why?
| | Humans | 19 | 2022 | 137585 | 0.100 |
Why?
| | Rotator Cuff | 1 | 2012 | 47 | 0.090 |
Why?
| | Protein Conformation | 13 | 1994 | 934 | 0.090 |
Why?
| | Quadriceps Muscle | 1 | 2013 | 133 | 0.090 |
Why?
| | Nucleotides | 2 | 1991 | 125 | 0.090 |
Why?
| | Suture Techniques | 1 | 2012 | 122 | 0.090 |
Why?
| | Magnetic Resonance Imaging | 3 | 2011 | 3566 | 0.090 |
Why?
| | RNA, Fungal | 1 | 1991 | 72 | 0.090 |
Why?
| | RNA, Ribosomal, 18S | 1 | 1990 | 26 | 0.090 |
Why?
| | Protein Biosynthesis | 5 | 1991 | 433 | 0.090 |
Why?
| | Tendons | 1 | 2011 | 111 | 0.090 |
Why?
| | Adult | 7 | 2018 | 37929 | 0.090 |
Why?
| | Retrospective Studies | 4 | 2013 | 15657 | 0.080 |
Why?
| | Arthroscopy | 1 | 2012 | 222 | 0.080 |
Why?
| | Poliovirus | 3 | 1990 | 85 | 0.080 |
Why?
| | RNA, Ribosomal, 23S | 1 | 1990 | 14 | 0.080 |
Why?
| | Medial Collateral Ligament, Knee | 1 | 2009 | 7 | 0.080 |
Why?
| | Peptides | 3 | 1994 | 985 | 0.080 |
Why?
| | Anterior Cruciate Ligament Reconstruction | 1 | 2011 | 143 | 0.080 |
Why?
| | Interferon Type I | 1 | 1990 | 140 | 0.080 |
Why?
| | Male | 14 | 2018 | 67762 | 0.070 |
Why?
| | Health Care Costs | 1 | 2011 | 398 | 0.070 |
Why?
| | Saccharomyces cerevisiae | 1 | 1991 | 557 | 0.060 |
Why?
| | RNA, Bacterial | 3 | 1988 | 190 | 0.060 |
Why?
| | Osmolar Concentration | 4 | 1991 | 171 | 0.060 |
Why?
| | Buffers | 3 | 1990 | 56 | 0.060 |
Why?
| | Young Adult | 3 | 2013 | 13209 | 0.060 |
Why?
| | Knee Joint | 2 | 2002 | 409 | 0.060 |
Why?
| | Peptide Initiation Factors | 1 | 1983 | 16 | 0.050 |
Why?
| | Heel | 1 | 2002 | 9 | 0.050 |
Why?
| | Contracture | 1 | 2002 | 20 | 0.050 |
Why?
| | HeLa Cells | 4 | 1990 | 636 | 0.050 |
Why?
| | Quality-Adjusted Life Years | 2 | 2012 | 113 | 0.050 |
Why?
| | Probability | 2 | 2012 | 304 | 0.040 |
Why?
| | Anticodon | 3 | 1988 | 24 | 0.040 |
Why?
| | Range of Motion, Articular | 2 | 1993 | 393 | 0.040 |
Why?
| | Muscle, Skeletal | 1 | 2010 | 1724 | 0.040 |
Why?
| | Affinity Labels | 1 | 1980 | 26 | 0.040 |
Why?
| | Dictyostelium | 1 | 1980 | 10 | 0.040 |
Why?
| | Halobacterium | 1 | 1979 | 3 | 0.040 |
Why?
| | Geobacillus stearothermophilus | 1 | 1979 | 12 | 0.040 |
Why?
| | Nucleic Acid Denaturation | 3 | 1990 | 32 | 0.040 |
Why?
| | Morphogenesis | 2 | 1991 | 166 | 0.040 |
Why?
| | Female | 7 | 2022 | 73304 | 0.040 |
Why?
| | Cost-Benefit Analysis | 2 | 2012 | 591 | 0.040 |
Why?
| | Ribonucleoproteins | 3 | 1991 | 105 | 0.040 |
Why?
| | Risk Factors | 1 | 2013 | 10388 | 0.040 |
Why?
| | Lithium | 1 | 1978 | 43 | 0.040 |
Why?
| | Viral Proteins | 2 | 1981 | 342 | 0.040 |
Why?
| | Protein Binding | 5 | 1991 | 2224 | 0.040 |
Why?
| | Leg Injuries | 2 | 2013 | 25 | 0.030 |
Why?
| | Temperature | 4 | 1989 | 679 | 0.030 |
Why?
| | Cell Cycle | 1 | 1980 | 601 | 0.030 |
Why?
| | Liver | 2 | 1983 | 1943 | 0.030 |
Why?
| | Polyribonucleotides | 1 | 1976 | 1 | 0.030 |
Why?
| | RNA, Viral | 2 | 1980 | 656 | 0.030 |
Why?
| | Binding Sites | 7 | 1988 | 1303 | 0.030 |
Why?
| | Surveys and Questionnaires | 1 | 2009 | 5778 | 0.030 |
Why?
| | Image Processing, Computer-Assisted | 2 | 1992 | 752 | 0.030 |
Why?
| | Bacterial Proteins | 4 | 1991 | 879 | 0.030 |
Why?
| | Eukaryotic Cells | 2 | 1988 | 40 | 0.030 |
Why?
| | Molecular Sequence Data | 2 | 1990 | 2900 | 0.030 |
Why?
| | Cyclic GMP | 1 | 1975 | 93 | 0.030 |
Why?
| | Fluorenes | 1 | 1975 | 44 | 0.030 |
Why?
| | Structure-Activity Relationship | 3 | 1990 | 570 | 0.030 |
Why?
| | Computers | 2 | 1986 | 70 | 0.030 |
Why?
| | Protein Denaturation | 2 | 1990 | 74 | 0.030 |
Why?
| | Models, Structural | 4 | 1988 | 40 | 0.030 |
Why?
| | Guanosine Triphosphate | 2 | 1993 | 91 | 0.030 |
Why?
| | Palpation | 1 | 1993 | 15 | 0.030 |
Why?
| | Thermus thermophilus | 1 | 1993 | 19 | 0.030 |
Why?
| | Tobacco Mosaic Virus | 1 | 1992 | 3 | 0.020 |
Why?
| | Shoulder | 1 | 1993 | 89 | 0.020 |
Why?
| | Histones | 3 | 1975 | 636 | 0.020 |
Why?
| | Statistics as Topic | 2 | 1984 | 307 | 0.020 |
Why?
| | RNA | 2 | 1976 | 921 | 0.020 |
Why?
| | Peripheral Vascular Diseases | 1 | 1993 | 103 | 0.020 |
Why?
| | Fractures, Spontaneous | 1 | 1992 | 15 | 0.020 |
Why?
| | Physical Examination | 1 | 1993 | 241 | 0.020 |
Why?
| | Organogold Compounds | 1 | 1991 | 5 | 0.020 |
Why?
| | Peptide Biosynthesis | 1 | 1991 | 13 | 0.020 |
Why?
| | Decision Trees | 1 | 2011 | 93 | 0.020 |
Why?
| | Base Sequence | 3 | 1990 | 2181 | 0.020 |
Why?
| | X-Ray Diffraction | 1 | 1991 | 104 | 0.020 |
Why?
| | Shoulder Joint | 1 | 1993 | 173 | 0.020 |
Why?
| | Movement | 1 | 1993 | 278 | 0.020 |
Why?
| | Joint Instability | 1 | 1993 | 167 | 0.020 |
Why?
| | Electron Probe Microanalysis | 1 | 1990 | 3 | 0.020 |
Why?
| | Methyltransferases | 1 | 1991 | 78 | 0.020 |
Why?
| | Hydroxyapatites | 1 | 1990 | 13 | 0.020 |
Why?
| | DNA Helicases | 3 | 1981 | 145 | 0.020 |
Why?
| | Sequence Homology, Nucleic Acid | 1 | 1990 | 155 | 0.020 |
Why?
| | Prosthesis Design | 1 | 1993 | 327 | 0.020 |
Why?
| | Gold | 1 | 1991 | 118 | 0.020 |
Why?
| | Oligodeoxyribonucleotides | 1 | 1990 | 143 | 0.020 |
Why?
| | Organometallic Compounds | 1 | 1991 | 111 | 0.020 |
Why?
| | Radiography | 1 | 1993 | 822 | 0.020 |
Why?
| | Muscle Contraction | 1 | 1993 | 424 | 0.020 |
Why?
| | Phosphorus | 1 | 1990 | 97 | 0.020 |
Why?
| | Staining and Labeling | 2 | 1982 | 150 | 0.020 |
Why?
| | Antibody-Dependent Cell Cytotoxicity | 1 | 1989 | 20 | 0.020 |
Why?
| | Reoperation | 1 | 2012 | 573 | 0.020 |
Why?
| | Electrophoresis, Polyacrylamide Gel | 1 | 1990 | 345 | 0.020 |
Why?
| | Computer Simulation | 1 | 1994 | 978 | 0.020 |
Why?
| | Antigens, Surface | 1 | 1989 | 154 | 0.020 |
Why?
| | Bone Neoplasms | 1 | 1992 | 247 | 0.020 |
Why?
| | RNA, Transfer, Amino Acid-Specific | 1 | 1988 | 4 | 0.020 |
Why?
| | RNA, Transfer, Val | 1 | 1988 | 3 | 0.020 |
Why?
| | Polynucleotides | 2 | 1980 | 14 | 0.020 |
Why?
| | Animals | 13 | 1992 | 36940 | 0.020 |
Why?
| | Genes, Bacterial | 2 | 1987 | 164 | 0.020 |
Why?
| | Decision Support Techniques | 1 | 2012 | 421 | 0.020 |
Why?
| | Hydrogen Bonding | 1 | 1988 | 163 | 0.020 |
Why?
| | Prokaryotic Cells | 1 | 1988 | 4 | 0.020 |
Why?
| | Spectrophotometry, Ultraviolet | 3 | 1980 | 86 | 0.020 |
Why?
| | Thermodynamics | 1 | 1990 | 407 | 0.020 |
Why?
| | Models, Biological | 3 | 1984 | 1783 | 0.020 |
Why?
| | Recombinant Proteins | 1 | 1990 | 1353 | 0.020 |
Why?
| | Proteins | 1 | 1973 | 1009 | 0.020 |
Why?
| | Capsid | 2 | 1977 | 93 | 0.020 |
Why?
| | Water | 1 | 1990 | 460 | 0.020 |
Why?
| | Drug Stability | 2 | 1979 | 167 | 0.020 |
Why?
| | Amino Acid Sequence | 1 | 1990 | 2139 | 0.020 |
Why?
| | Molecular Conformation | 3 | 1978 | 145 | 0.020 |
Why?
| | Cell Nucleus | 2 | 1981 | 620 | 0.010 |
Why?
| | Cricetinae | 1 | 1985 | 289 | 0.010 |
Why?
| | Calcium | 1 | 1990 | 1199 | 0.010 |
Why?
| | Reproducibility of Results | 1 | 1992 | 3284 | 0.010 |
Why?
| | Species Specificity | 2 | 1989 | 585 | 0.010 |
Why?
| | Eukaryotic Initiation Factor-3 | 1 | 1983 | 4 | 0.010 |
Why?
| | DNA | 1 | 1971 | 1459 | 0.010 |
Why?
| | Azides | 2 | 1984 | 46 | 0.010 |
Why?
| | Follow-Up Studies | 1 | 1993 | 5131 | 0.010 |
Why?
| | Monosaccharide Transport Proteins | 1 | 1983 | 51 | 0.010 |
Why?
| | Symporters | 1 | 1983 | 66 | 0.010 |
Why?
| | Kinetics | 3 | 1991 | 1670 | 0.010 |
Why?
| | Antibodies, Monoclonal | 1 | 1989 | 1430 | 0.010 |
Why?
| | Pattern Recognition, Automated | 1 | 1982 | 73 | 0.010 |
Why?
| | In Vitro Techniques | 1 | 1983 | 1092 | 0.010 |
Why?
| | Membrane Transport Proteins | 1 | 1983 | 162 | 0.010 |
Why?
| | Nucleoproteins | 1 | 1981 | 27 | 0.010 |
Why?
| | Benzopyrenes | 2 | 1978 | 4 | 0.010 |
Why?
| | T-Lymphocytes | 1 | 1989 | 1996 | 0.010 |
Why?
| | Escherichia coli Proteins | 1 | 1983 | 200 | 0.010 |
Why?
| | Cell Line | 1 | 1985 | 2847 | 0.010 |
Why?
| | Photolysis | 1 | 1980 | 91 | 0.010 |
Why?
| | Photochemistry | 1 | 1980 | 134 | 0.010 |
Why?
| | DNA, Single-Stranded | 1 | 1980 | 118 | 0.010 |
Why?
| | Immunoglobulin G | 2 | 1989 | 893 | 0.010 |
Why?
| | Adolescent | 2 | 2002 | 21513 | 0.010 |
Why?
| | Cross-Linking Reagents | 1 | 1980 | 217 | 0.010 |
Why?
| | Arm Injuries | 1 | 1999 | 26 | 0.010 |
Why?
| | Antibodies | 2 | 1984 | 410 | 0.010 |
Why?
| | Phenylalanine | 1 | 1979 | 68 | 0.010 |
Why?
| | Middle Aged | 3 | 2012 | 33479 | 0.010 |
Why?
| | Ethers, Cyclic | 1 | 1978 | 8 | 0.010 |
Why?
| | Transcription, Genetic | 1 | 1985 | 1457 | 0.010 |
Why?
| | Oligoribonucleotides | 1 | 1978 | 52 | 0.010 |
Why?
| | Epoxy Compounds | 1 | 1978 | 33 | 0.010 |
Why?
| | DNA, Viral | 1 | 1980 | 364 | 0.010 |
Why?
| | Bacteria | 1 | 1985 | 858 | 0.010 |
Why?
| | Kidney | 1 | 1985 | 1468 | 0.010 |
Why?
| | Oligonucleotides | 1 | 1978 | 148 | 0.010 |
Why?
| | Antigen-Antibody Reactions | 1 | 1976 | 55 | 0.010 |
Why?
| | Solvents | 2 | 1978 | 109 | 0.010 |
Why?
| | Predictive Value of Tests | 1 | 2002 | 2031 | 0.010 |
Why?
| | Methods | 2 | 1973 | 65 | 0.010 |
Why?
| | Polyribosomes | 1 | 1975 | 24 | 0.010 |
Why?
| | United States | 1 | 2013 | 14841 | 0.010 |
Why?
| | Spectrum Analysis | 2 | 1973 | 91 | 0.010 |
Why?
| | Cattle | 3 | 1975 | 984 | 0.010 |
Why?
| | Magnetic Resonance Spectroscopy | 3 | 1975 | 611 | 0.010 |
Why?
| | Gene Expression Regulation | 1 | 1985 | 2607 | 0.010 |
Why?
| | Isomerism | 1 | 1975 | 56 | 0.010 |
Why?
| | Chromatography, Ion Exchange | 1 | 1975 | 55 | 0.010 |
Why?
| | Hydrogen-Ion Concentration | 2 | 1975 | 560 | 0.010 |
Why?
| | Phenobarbital | 1 | 1974 | 19 | 0.010 |
Why?
| | Acetamides | 1 | 1975 | 36 | 0.010 |
Why?
| | DNA-Binding Proteins | 1 | 1981 | 1502 | 0.010 |
Why?
| | Guanidines | 1 | 1973 | 39 | 0.010 |
Why?
| | Serotonin | 1 | 1975 | 323 | 0.010 |
Why?
| | Urea | 1 | 1973 | 81 | 0.010 |
Why?
| | Pharmaceutical Preparations | 1 | 1974 | 179 | 0.010 |
Why?
| | Mice | 3 | 1989 | 17787 | 0.010 |
Why?
| | Cytosine | 1 | 1991 | 49 | 0.010 |
Why?
| | Rehabilitation Centers | 1 | 1992 | 39 | 0.010 |
Why?
| | 5-Methylcytosine | 1 | 1991 | 22 | 0.010 |
Why?
| | Guanine | 1 | 1991 | 79 | 0.010 |
Why?
| | Methylation | 1 | 1991 | 230 | 0.010 |
Why?
| | Chromatin | 1 | 1975 | 519 | 0.010 |
Why?
| | Substrate Specificity | 1 | 1991 | 372 | 0.010 |
Why?
| | Durapatite | 1 | 1990 | 37 | 0.010 |
Why?
| | Models, Molecular | 2 | 1991 | 1570 | 0.010 |
Why?
| | Reference Standards | 1 | 1990 | 186 | 0.010 |
Why?
| | Prospective Studies | 1 | 2002 | 7604 | 0.010 |
Why?
| | Thymectomy | 1 | 1989 | 15 | 0.010 |
Why?
| | Mice, Inbred Strains | 1 | 1989 | 409 | 0.000 |
Why?
| | Immunoglobulin M | 1 | 1989 | 289 | 0.000 |
Why?
| | T-Phages | 1 | 1987 | 18 | 0.000 |
Why?
| | DNA-Directed RNA Polymerases | 1 | 1987 | 57 | 0.000 |
Why?
| | Ligands | 1 | 1988 | 664 | 0.000 |
Why?
| | Plasmids | 1 | 1987 | 363 | 0.000 |
Why?
| | Flow Cytometry | 1 | 1989 | 1178 | 0.000 |
Why?
| | DNA, Recombinant | 1 | 1985 | 47 | 0.000 |
Why?
| | Cell-Free System | 1 | 1985 | 53 | 0.000 |
Why?
| | Genes | 1 | 1985 | 230 | 0.000 |
Why?
| | Sodium Chloride | 2 | 1975 | 142 | 0.000 |
Why?
| | Antigen-Antibody Complex | 1 | 1984 | 90 | 0.000 |
Why?
| | Genetic Engineering | 1 | 1985 | 93 | 0.000 |
Why?
| | Thymus Gland | 2 | 1975 | 312 | 0.000 |
Why?
| | Cloning, Molecular | 1 | 1985 | 534 | 0.000 |
Why?
| | gamma-Aminobutyric Acid | 1 | 1984 | 198 | 0.000 |
Why?
| | Epitopes | 1 | 1984 | 479 | 0.000 |
Why?
| | Promoter Regions, Genetic | 1 | 1985 | 1250 | 0.000 |
Why?
| | Aged, 80 and over | 1 | 1992 | 7635 | 0.000 |
Why?
| | Dinitrophenols | 1 | 1979 | 8 | 0.000 |
Why?
| | Nucleic Acids | 1 | 1979 | 71 | 0.000 |
Why?
| | Valine | 1 | 1979 | 82 | 0.000 |
Why?
| | Immunoassay | 1 | 1979 | 115 | 0.000 |
Why?
| | Chemistry | 1 | 1978 | 45 | 0.000 |
Why?
| | Chemical Phenomena | 1 | 1978 | 83 | 0.000 |
Why?
| | Centrifugation, Density Gradient | 1 | 1976 | 41 | 0.000 |
Why?
| | Carcinoma, Ehrlich Tumor | 1 | 1975 | 1 | 0.000 |
Why?
| | Puromycin | 1 | 1975 | 10 | 0.000 |
Why?
| | Cycloheximide | 1 | 1975 | 55 | 0.000 |
Why?
| | Aminoacylation | 1 | 1975 | 14 | 0.000 |
Why?
| | Mutation | 1 | 1987 | 3958 | 0.000 |
Why?
| | Reserpine | 1 | 1975 | 3 | 0.000 |
Why?
| | Sea Urchins | 1 | 1975 | 7 | 0.000 |
Why?
| | Spectrophotometry, Infrared | 1 | 1975 | 54 | 0.000 |
Why?
| | Adenylyl Cyclases | 1 | 1975 | 87 | 0.000 |
Why?
| | Binding, Competitive | 1 | 1975 | 202 | 0.000 |
Why?
| | Dealkylation | 1 | 1974 | 3 | 0.000 |
Why?
| | Cytochrome Reductases | 1 | 1974 | 3 | 0.000 |
Why?
| | Oxidoreductases, N-Demethylating | 1 | 1974 | 16 | 0.000 |
Why?
| | Hydroxylation | 1 | 1974 | 39 | 0.000 |
Why?
| | Mixed Function Oxygenases | 1 | 1974 | 40 | 0.000 |
Why?
| | Microsomes, Liver | 1 | 1974 | 86 | 0.000 |
Why?
| | Guinea Pigs | 1 | 1974 | 158 | 0.000 |
Why?
| | Aniline Compounds | 1 | 1974 | 102 | 0.000 |
Why?
| | Cytochrome P-450 Enzyme System | 1 | 1974 | 155 | 0.000 |
Why?
| | Rabbits | 1 | 1975 | 794 | 0.000 |
Why?
| | Myocardial Contraction | 1 | 1975 | 341 | 0.000 |
Why?
| | Guanine Nucleotides | 1 | 1972 | 14 | 0.000 |
Why?
| | Neoplasm Proteins | 1 | 1975 | 434 | 0.000 |
Why?
| | Animals, Newborn | 1 | 1974 | 844 | 0.000 |
Why?
| | Piperazines | 1 | 1974 | 350 | 0.000 |
Why?
| | Aged | 1 | 1992 | 23961 | 0.000 |
Why?
| | Blood Platelets | 1 | 1975 | 408 | 0.000 |
Why?
| | Postpartum Period | 1 | 1974 | 340 | 0.000 |
Why?
| | Amino Acids | 1 | 1975 | 497 | 0.000 |
Why?
| | Gestational Age | 1 | 1974 | 910 | 0.000 |
Why?
| | Dose-Response Relationship, Drug | 1 | 1975 | 2057 | 0.000 |
Why?
| | Adenosine Triphosphate | 1 | 1972 | 491 | 0.000 |
Why?
| | Fetus | 1 | 1974 | 806 | 0.000 |
Why?
| | RNA, Messenger | 1 | 1976 | 2833 | 0.000 |
Why?
| | Rats | 1 | 1975 | 5647 | 0.000 |
Why?
| | Anti-Bacterial Agents | 1 | 1975 | 1809 | 0.000 |
Why?
| | Mice, Inbred C57BL | 1 | 1975 | 5757 | 0.000 |
Why?
| | Aging | 1 | 1974 | 1864 | 0.000 |
Why?
| | Pregnancy | 1 | 1974 | 6763 | 0.000 |
Why?
|
|
Boublik's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|